Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
Biopharmalex 2018-08-23 5:41 pm By Miklos Bolza | Sydney
Please login to bookmark Close

An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy’s Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au